Gyeonggi-do, South Korea

Jung Hwan Kim


Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jung Hwan Kim: Innovator in Pharmaceutical Chemistry

Introduction

Jung Hwan Kim is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific diseases.

Latest Patents

One of his key patents is the novel [1,2,4]triazolo[4,3-a]quinoxaline derivative. This patent includes a method for preparing the compound and a pharmaceutical composition aimed at preventing or treating bromodomain extra-terminal (BET) protein-related diseases. These diseases include various forms of cancer and autoimmune disorders, with the compound serving as an active ingredient.

Career Highlights

Jung Hwan Kim has worked with reputable organizations such as Dong Wha Pharm. Co., Ltd. and the Korea Research Institute of Chemical Technology. His work in these institutions has allowed him to advance his research and contribute to the development of innovative pharmaceutical solutions.

Collaborations

Some of his notable coworkers include Kwangho Lee and Gildon Choi, who have collaborated with him on various projects in the field of pharmaceutical research.

Conclusion

Jung Hwan Kim's contributions to pharmaceutical chemistry, particularly through his innovative patents, highlight his role as a significant inventor in the industry. His work continues to impact the development of treatments for critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…